Robert Gut

1.8k citations

40 papers · 1.1k indexed · h-index 21

Impact in

Hematology top 2%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Endocrinology, Diabetes and Metabolism top 2%
- Menopause: Health Impacts and Treatments
- Growth Hormone and Insulin-like Growth Factors

Papers in ⓘ

Hematology 23
- Hemophilia Treatment and Research 23
- Platelet Disorders and Treatments 7
- Chronic Myeloid Leukemia Treatments 5
- Blood Coagulation and Thrombosis Mechanisms 5
Endocrinology, Diabetes and Metabolism 10
- Growth Hormone and Insulin-like Growth Factors 6

Co-authors: John Germak (9 shared papers)Lila E. Nachtigall (4 shared papers)David L. Cooper (16 shared papers)Judith L. Ross (7 shared papers)Peter A. Lee (6 shared papers)Michael Recht (11 shared papers)David F. Archer (3 shared papers)James A. Simon (3 shared papers)
Journals: Blood (8 papers)Haemophilia (6 papers)Obstetrics and Gynecology (3 papers)Value in Health (3 papers)Blood Coagulation & Fibrinolysis (2 papers)
Partner nations: United States Netherlands Italy

In The Last Decade

Robert Gut

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by Robert Gut

Since Specialization

Citations

This map shows the geographic impact of Robert Gut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Gut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Gut more than expected).

Fields of papers citing papers by Robert Gut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Gut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Gut. The network helps show where Robert Gut may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Gut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Gut Line = papers co-authored together Robert Gut links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy of Low-Dose Estradiol Vaginal Tablets in the Treatment of Atrophic Vaginitis Obstetrics and Gynecology ·Gloria Bachmann, Rogerio A. Løbo, Robert Gut, Lila E. Nachtigall, Morris Notelovitz	2008	121
2	Effective Treatment of Vaginal Atrophy With an Ultra–Low-Dose Estradiol Vaginal Tablet Obstetrics and Gynecology ·James A. Simon, Lila E. Nachtigall, Robert Gut, Eva Lang, David F. Archer, Wulf H. Utian	2008	120
3	Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study Haemophilia ·Michelle Witkop, Anne T. Neff, Tyler W. Buckner, Michael Wang, Katharine Batt, Craig M. Kessler, Doris Quon, Lisa Boggio, Michael Recht, Kim Baumann, Robert Gut, David L. Cooper, Christine L. Kempton	2017	99
4	Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B Blood Advances ·Annette von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe	2019	96
5	Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief Climacteric ·Nicholas Panay, Olavi Ylikorkala, David F. Archer, Robert Gut, Eva Lang	2007	69
6	Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia Value in Health ·Ellis J. Neufeld, Michael Recht, Hernan Sabio, Kapil Saxena, Caitlyn T. Solem, A. Simon Pickard, Robert Gut, David L. Cooper	2012	51
7	Endometrial Safety of Ultra-Low-Dose Estradiol Vaginal Tablets Obstetrics and Gynecology ·James A. Simon, Lila E. Nachtigall, Lian G. Ulrich, M. Eugster-Hausmann, Robert Gut	2010	49
8	Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study Haemophilia ·Christine L. Kempton, Michael Recht, Anne T. Neff, Michael Wang, Tyler W. Buckner, Amit Soni, Doris Quon, Michelle Witkop, Lisa Boggio, Robert Gut, David L. Cooper	2017	42
9	Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy Blood Advances ·Annette von Drygalski, Esteban Moreno Gómez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Robert Gut, Ricardo E. Dolmetsch, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe	2022	40
10	Assessment of acquired hemophilia patient demographics in the United States Blood Coagulation & Fibrinolysis ·Craig M. Kessler, D. Alice, Hamid Al‐Mondhiry, Robert Gut, David L. Cooper	2016	38
11	Factors Influencing the One- and Two-Year Growth Response in Children Treated with Growth Hormone: Analysis from an Observational Study International Journal of Pediatric Endocrinology ·Judith L. Ross, Peter A. Lee, Robert Gut, John Germak	2010	36
12	Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program® International Journal of Pediatric Endocrinology ·Peter A. Lee, John Germak, Robert Gut, Naum Khutoryansky, Judith L. Ross	2011	35
13	Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years Growth Hormone & IGF Research ·Judith L. Ross, Peter A. Lee, Robert Gut, John Germak	2015	31
14	Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry International Journal of Pediatric Endocrinology ·Peter A. Lee, Judith L. Ross, John Germak, Robert Gut	2012	28
15	Factors Influencing the One- and Two-Year Growth Response in Children Treated with Growth Hormone: Analysis from an Observational Study International Journal of Pediatric Endocrinology ·Judith L. Ross, PeterA Lee, Robert Gut, John Germak	2010	26
16	Impact of Age and Duration of Growth Hormone Therapy in Children with Turner Syndrome Hormone Research in Paediatrics ·Judith L. Ross, Peter A. Lee, Robert Gut, John Germak	2011	23
17	Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004–2008) Haemophilia ·Guy Young, David L. Cooper, Robert Gut, (unknown)	2012	23
18	Patient/Caregiver‐reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE) Haemophilia ·Guy Young, Amy D. Shapiro, Christopher Walsh, Ralph A. Gruppo, Robert Gut, David L. Cooper	2011	22
19	Trends In Growth Hormone Stimulation Testing And Growth Hormone Dosing In Adult Growth Hormone Deficiency Patients: Results From The Answer Program Endocrine Practice ·MurrayB. Gordon, RichardA. Levy, Robert Gut, John Germak	2015	21
20	Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE) Value in Health ·Michael Recht, Ellis J. Neufeld, Vivek R. Sharma, Caitlyn T. Solem, A. Simon Pickard, Robert Gut, David L. Cooper	2014	21

About Robert Gut

Robert Gut is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism, Genetics, Reproductive Medicine and Genetics, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (23 papers), Virus-based gene therapy research (7 papers), Platelet Disorders and Treatments (7 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers). The work is most often cited by research in Hematology (466 citations), Endocrinology, Diabetes and Metabolism (447 citations), Reproductive Medicine (110 citations), Genetics (359 citations) and Genetics (100 citations). Robert Gut has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include John Germak, Lila E. Nachtigall, David L. Cooper, Judith L. Ross, Peter A. Lee, Michael Recht, David F. Archer, James A. Simon, Craig M. Kessler and Gloria Bachmann. Their work appears in journals such as Blood, Haemophilia, Obstetrics and Gynecology, Value in Health and Blood Coagulation & Fibrinolysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact